Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hoguen Kim
Affiliation
Korea Advanced Institute of Science and Technology (KAIST)
ORCID
Career Start Year
1982
Papers
246
H Index
58
Expertise
CM4AI Collaborator
Emma Lundberg (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36710400
A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States.
Cancer Res
2023
36960042
<i>Fusobacterium nucleatum</i> induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers.
Front Cell Infect Microbiol
2023
36194907
Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
Stem Cell Res
2022
35592390
Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer.
Mol Ther Oncolytics
2022
34766501
Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role.
J Proteome Res
2021
33884649
Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.
Hepatology
2021
32410800
Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer.
Chin J Cancer Res
2020
31985234
Identification of ALDH6A1 as a Potential Molecular Signature in Hepatocellular Carcinoma via Quantitative Profiling of the Mitochondrial Proteome.
J Proteome Res
2020
33206527
Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth.
J Proteome Res
2020
32608200
mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
Yonsei Med J
2020
32184397
Grasp55<sup>-/-</sup> mice display impaired fat absorption and resistance to high-fat diet-induced obesity.
Nat Commun
2020
30604042
Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater.
Cancer Immunol Immunother
2019
31704735
VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.
Sci Immunol
2019
31804558
β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers.
Sci Rep
2019
31269945
Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
BMC Med Genomics
2019
31044541
Establishment of pancreatic cancer cell lines with endoscopic ultrasound-guided biopsy via conditionally reprogrammed cell culture.
Cancer Med
2019
30829612
Prognostic potential of the preoperative plasma complement factor B in resected pancreatic cancer: A pilot study.
Cancer Biomark
2019
30971066
Inter-observer Reproducibility in the Pathologic Diagnosis of Gastric Intraepithelial Neoplasia and Early Carcinoma in Endoscopic Submucosal Dissection Specimens: A Multi-center Study.
Cancer Res Treat
2019
29301793
<i>O</i>-GlcNAcylation of the Tumor Suppressor FOXO3 Triggers Aberrant Cancer Cell Growth.
Cancer Res
2018
30514259
Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
BMC Cancer
2018
29552289
Metabolic characteristics of solid pseudopapillary neoplasms of the pancreas: their relationships with high intensity <sup>18</sup>F-FDG PET images.
Oncotarget
2018
29277888
Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
Int J Cancer
2018
27440273
Sustained Mutant KIT Activation in the Golgi Complex Is Mediated by PKC-θ in Gastrointestinal Stromal Tumors.
Clin Cancer Res
2017
28455965
Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.
Oncotarget
2017
29158530
mRNAs containing NMD-competent premature termination codons are stabilized and translated under UPF1 depletion.
Sci Rep
2017
29065965
Identification of specifically activated angiogenic molecules in HMGB-1-induced angiogenesis.
BMB Rep
2017
29113306
Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis.
Oncotarget
2017
29212159
LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
Oncotarget
2017
28561935
Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.
Histopathology
2017
28865435
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
BMC Cancer
2017
27699609
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Ann Surg Oncol
2017
27324335
Probe-based confocal laser endomicroscopy for evaluating the submucosal invasion of colorectal neoplasms.
Surg Endosc
2017
26781991
NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.
Cancer Res
2016
26324820
Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection?
Gastric Cancer
2016
26621523
Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep).
Gastric Cancer
2016
27631203
The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer: A retrospective study of 428 patients.
Medicine (Baltimore)
2016
28025472
[Molecular Classification of Colorectal Cancers and Clinical Application].
Korean J Gastroenterol
2016
27536871
Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors.
PLoS One
2016
27149404
Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses.
PLoS One
2016
27450278
Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer.
J Surg Oncol
2016
27294323
Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.
Nat Chem Biol
2016
27228287
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Br J Cancer
2016
27495277
Erratum to: Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer.
Ann Surg Oncol
2016
27469120
Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer.
Ann Surg Oncol
2016
26907784
Are new criteria for mixed histology necessary for endoscopic resection in early gastric cancer?
Pathol Res Pract
2016
26705682
A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis.
Radiother Oncol
2016
27002480
Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
Cancer Sci
2016
25231249
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
J Appl Toxicol
2015
26435392
Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues.
J Proteome Res
2015
26509967
Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹â¸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
PLoS One
2015
1 - 50 of 246
Column Actions
Search
Recommended Authors
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year
2012
Number of shared co-authors
1
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year
2008
Number of shared co-authors
1
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year
2007
Number of shared co-authors
0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year
2007
Number of shared co-authors
0
Kurt W Fisher
University of Nebraska Medical Center
Career Start Year
2004
Number of shared co-authors
2
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year
2003
Number of shared co-authors
0
Yongwei Yu
Changhai Hospital
Career Start Year
2001
Number of shared co-authors
0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year
2001
Number of shared co-authors
0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year
2001
Number of shared co-authors
0
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year
2000
Number of shared co-authors
0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
2
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year
1995
Number of shared co-authors
4
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year
1994
Number of shared co-authors
2
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Career Start Year
1994
Number of shared co-authors
1
Bhaskar Kallakury
Georgetown University
Career Start Year
1993
Number of shared co-authors
0
Remond J A Fijneman
The Netherlands Cancer Institute
Career Start Year
1993
Number of shared co-authors
0
Phillip Buckhaults
University of South Carolina
Career Start Year
1993
Number of shared co-authors
0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
0
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year
1992
Number of shared co-authors
1
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year
1992
Number of shared co-authors
3
Nicholas J Hawkins
School of Public Health, Imperial College London
Career Start Year
1990
Number of shared co-authors
0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year
1989
Number of shared co-authors
0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1989
Number of shared co-authors
1
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year
1988
Number of shared co-authors
2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year
1986
Number of shared co-authors
1
Christopher L Corless
Oregon Health & Science University
Career Start Year
1985
Number of shared co-authors
1
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year
1983
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Young-Ki Paik
College of Life Sciences and Biotechnology, Yonsei University
Co-authored papers
38
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers
16
Hyoung-Joo Lee
Yonsei University
Co-authored papers
13
Seul-Ki Jeong
Seul-Ki Jeong Neurology Clinic
Co-authored papers
10
Sang Yun Cho
Co-authored papers
10
Jong Shin Yoo
Co-authored papers
10
William S Hancock
Northeastern University
Co-authored papers
9
Stan Krajewski
Cellstan-Immunoquant Inc.
Co-authored papers
6
Min-Seok Kwon
Co-authored papers
5
Jong-Sun Lim
Yonsei Proteome Research Center, Yonsei University
Co-authored papers
5
Susan Fanayan
Macquarie University
Co-authored papers
4
Jong Won Kim
Co-authored papers
4
Yong-Hoon Kim
Kangwon National University School of Medicine
Co-authored papers
3
Bert Vogelstein
Co-authored papers
3
Michael Snyder
Stanford University
Co-authored papers
3
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Co-authored papers
3
Fangfei Yan
Beijing Mental Health Care Institute
Co-authored papers
3
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers
3
Manveen K Sethi
Center for Biomedical Mass Spectrometry, Boston University
Co-authored papers
3
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers
2
Yue Zhang
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
Co-authored papers
2
Amos Bairoch
University of Geneva
Co-authored papers
2
Ronald C Beavis
University of Manitoba
Co-authored papers
2
Mee-Yon Cho
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Co-authored papers
2
Edison T Liu
USA The Jackson Laboratory Cancer Center
Co-authored papers
2
Mark S Baker
Macquarie University
Co-authored papers
2
Nicolle H Packer
Co-authored papers
2
Hogune Im
Genome Opinion Inc.
Co-authored papers
2
Rui Chen
Stanford University
Co-authored papers
2
Ruedi Aebersold
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers
2
1 - 30